The fraction of patients with a missense mutation carrying at least one APOE ε4 allele (66/96, 68.8%) is significantly higher compared to the full AD cohort (790/1350, 58.5%) (p = 0.002) (Additional file 1: Table S8) [9]. Here, APOE is linked to Alzheimer disease.